You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   Feb 22, 2024 at 11:33: PM
Administrator
Staff member
via The $260 million fund will be used to back startups working on new drugmaking approaches like protein degraders and RNA therapies.
article source
<